Rehovot, Israel

Avigdor Scherz

USPTO Granted Patents = 26 

 

 

Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 107(Granted Patents)


Location History:

  • Rechovot, IL (2008 - 2011)
  • Rehovot, IL (1997 - 2022)

Company Filing History:


Years Active: 1997-2022

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: Avigdor Scherz: A Notable Inventor in the Field of Cancer Treatment and Ophthalmology

Introduction:

Avigdor Scherz is an accomplished inventor and researcher hailing from Rehovot, Israel. With a strong background in biotechnology, his contributions have significantly impacted the fields of cancer treatment and ophthalmology. Holding an impressive number of 26 patents, Scherz has dedicated his career to developing innovative therapies and pioneering advancements in medical science.

Latest Patents:

Among Avigdor Scherz's notable inventions are two groundbreaking patents that have garnered attention in the medical community. The first patent involves combinational therapies for cancer treatment comprising an anti-myeloid-derived suppressor cells agent (anti-MDSCs) and a bacteriochlorophyll derivative (Bchl-D). The treatment procedure includes sequential administration of the anti-MDSC agent and the Bchl-D, followed by photodynamic therapy (PDT) or vascular targeted PDT (VTP). This unique approach holds great promise for more effective cancer treatments.

The second patent revolves around the use of (bacterio)chlorophyll photosensitizers for the treatment of eye diseases and disorders. Scherz's ophthalmic composition utilizes chlorophyll or bacteriochlorophyll compounds for photodynamic treatment (PDT) of conditions associated with corneal or scleral anomalies, such as corneal thinning and scleral stretching. This invention represents a significant advancement in the treatment of eye-related ailments.

Career Highlights:

Avigdor Scherz has made significant contributions during his tenure at companies such as Yeda Research and Development Co Ltd. and SeeThrough Ltd. At Yeda Research and Development Co Ltd., a renowned Israeli technology transfer company, he worked tirelessly to bridge the gap between academic research and commercial applications. Scherz's work at SeeThrough Ltd., a company specializing in photodynamic therapy, further solidified his expertise in the field, as he played a crucial role in advancing their innovative ophthalmic treatments.

Collaborations:

Throughout his career, Avigdor Scherz has had the opportunity to collaborate with esteemed colleagues, further enriching his research and development efforts. Notably, he has worked closely with Yoram Salomon and Alexander Brandis, both accomplished individuals in their respective fields. These collaborations have facilitated the exchange of ideas and the advancement of groundbreaking research, contributing to Scherz's prolific patent portfolio.

Conclusion:

Avigdor Scherz's impact on the fields of cancer treatment and ophthalmology cannot be overstated. Through his patents and career accomplishments, Scherz has demonstrated a deep commitment to scientific innovation and improving medical treatments. As he continues to push the boundaries of possibility in these areas, it is clear that his contributions will have a lasting impact on the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…